Troubled Dimension Therapeutics Sold in All-Stock Deal Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex Keown, BioSpace.com Breaking News StaffROCKVILLE, Md… Source: BioSpace You Might Also Like Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017 FDA Grants Orphan Drug Designation To Prometic's PBI-4050 Drug For The Treatment Of Alstr??m Syndrome March 2, 2017 Lamellar Biomedical Ltd Raises ??5.75 Million In Series C Fund Raising Led By May 7, 2017
Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017
FDA Grants Orphan Drug Designation To Prometic's PBI-4050 Drug For The Treatment Of Alstr??m Syndrome March 2, 2017
